Aptinyx (APTX) Reports In-Line Q1 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Aptinyx Reports First Quarter 2021 Financial Results and Highlights
May 13, 2021 4:05 PM EDTEnrollment on track in both Phase 2b studies of NYX-2925 in chronic paindata readouts expected 1H 2022
Preparing for NYX-783 Phase 2b PTSD study following recent FDA meetingstudy initiation expected in 2H 2021
Recommenced Phase 2 study of NYX-458 in patients with cognitive impairmentdata readout expected 2H 2022
$146.8 million cash position expected to support operations through multiple Phase 2 readouts and into 2023
Conference call today at 5:00 p.m. ET
EVANSTON, Ill.--(BUSINESS WIRE)-- Aptinyx Inc. (Nasdaq:... More
